Literature DB >> 11070003

Lentivirus Nef specifically activates Pak2.

V K Arora1, R P Molina, J L Foster, J L Blakemore, J Chernoff, B L Fredericksen, J V Garcia.   

Abstract

Nef proteins from human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) have been found to associate with an active cellular serine/threonine kinase designated Nef-associated kinase (Nak). The exact identity of Nak remains controversial, with two recent studies indicating that Nak may be either Pak1 or Pak2. In this study, we investigated the hypothesis that such discrepancies arise from the use of different Nef alleles or different cell types by individual investigators. We first confirm that Pak2 but not Pak1 is cleaved by caspase 3 in vitro and then demonstrate that Nak is caspase 3 sensitive, regardless of Nef allele or cell type used. We tested nef alleles from three lentiviruses (HIV-1 SF2, HIV-1 NL4-3, and SIVmac239) and used multiple cell lines of myeloid, lymphoid, and nonhematopoietic origin to evaluate the identity of Nak. We demonstrate that ectopically expressed Pak2 can substitute for Nak, while ectopically expressed Pak1 cannot. We then show that Nef specifically mediates the robust activation of ectopically expressed Pak2, directly demonstrating that Nef regulates Pak2 activity and does not merely associate with activated Pak2. We report that most of the active Pak2 is found bound to Nef, although a fraction is not. In contrast, only a small amount of Nef is found associated with Pak2. We conclude that Nak is Pak2 and that Nef specifically mediates Pak2 activation in a low-abundance complex. These results will facilitate both the elucidation of the role of Nef in pathogenesis and the development of specific inhibitors of this highly conserved function of Nef.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070003      PMCID: PMC113188          DOI: 10.1128/jvi.74.23.11081-11087.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Emerging from the Pak: the p21-activated protein kinase family.

Authors:  M A Sells; J Chernoff
Journal:  Trends Cell Biol       Date:  1997-04       Impact factor: 20.808

Review 2.  HIV-1 auxiliary proteins: making connections in a dying cell.

Authors:  B R Cullen
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

3.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

4.  Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems.

Authors:  T Luo; J L Douglas; R L Livingston; J V Garcia
Journal:  Virology       Date:  1998-02-15       Impact factor: 3.616

5.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

6.  The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent.

Authors:  T Luo; J V Garcia
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner.

Authors:  J Lama; A Mangasarian; D Trono
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

8.  Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members.

Authors:  J A Frost; S Xu; M R Hutchison; S Marcus; M H Cobb
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

9.  Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity.

Authors:  B N Walter; Z Huang; R Jakobi; P T Tuazon; E S Alnemri; G Litwack; J A Traugh
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  38 in total

Review 1.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 2.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

3.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

4.  Human N-myristoyltransferases form stable complexes with lentiviral nef and other viral and cellular substrate proteins.

Authors:  Brian T Hill; Jacek Skowronski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 5.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

6.  Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.

Authors:  Eduardo O'Neill; Lillian S Kuo; John F Krisko; Diana R Tomchick; J Victor Garcia; John L Foster
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Intra- and intersubtype alternative Pak2-activating structural motifs of human immunodeficiency virus type 1 Nef.

Authors:  Eduardo O'Neill; Laura L Baugh; Vladimir A Novitsky; Myron E Essex; J Victor Garcia
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice.

Authors:  Kimberly Schmitt; Dipu Mohan Kumar; James Curlin; Leila Remling-Mulder; Mark Stenglein; Shelby O'Connor; Preston Marx; Ramesh Akkina
Journal:  Virology       Date:  2017-07-24       Impact factor: 3.616

9.  Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex.

Authors:  Alexa Raney; Lillian S Kuo; Laura L Baugh; John L Foster; J Victor Garcia
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

10.  Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates.

Authors:  J L Foster; R P Molina; T Luo; V K Arora; Y Huang; D D Ho; J V Garcia
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.